Thomas Equels, CEO & President, Director at AIM ImmunoTech, holds 716.46K shares in AIM ImmunoTech (Ticker: AIM). Most recently, Thomas Equels Bought $75,758 shares of AIM ImmunoTech on Mar 18, 2024 for an estimated value of 25.00K.
What is the percentage of profitable transactions made by Thomas Equels?
The percentage of profitable transactions made by Thomas Equels is 15%.
What is the average return per transaction made by Thomas Equels?
The average return per transaction made by Thomas Equels is -44.50%.
What stocks does Thomas Equels hold?
Thomas Equels holds: AIM stocks.
What was Thomas Equels’s latest transaction?
Thomas Equels latest transaction was an Informative Buy of $25.00K.
What was Thomas Equels's most profitable transaction?
Thomas Equels’s most profitable transaction was an Informative Buy of AIM stock on March 18, 2024. The return on the trade was 24.00%.
What is Thomas Equels's role in AIM ImmunoTech?
Thomas Equels's role in AIM ImmunoTech is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.